Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
The GLP-1 drug pipeline has become one of the most consequential and closely watched in modern pharmaceutical history
Will I Have to Take a GLP-1 Forever
This report describe the results from the phase III trial assessing anifrolumab in non-renal SLE, which led to its approval
For patients seeking safer, long-term results, physician-guided care is generally the more comprehensive approach
US$ 27.30
US$ 24.65
US$ 21.24
US$ 27.55
US$ 24.83
US$ 24.16
US$ 24.54
US$ 29.23
